Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer.
Publication Type | Academic Article |
Authors | Ivanidze J, Subramanian K, Youn T, Cigler T, Osborne J, Magge R, Balogun O, Knisely J, Ramakrishna R |
Journal | Neurooncol Adv |
Volume | 3 |
Issue | 1 |
Pagination | vdab178 |
Date Published | 11/30/2021 |
ISSN | 2632-2498 |
DOI | 10.1093/noajnl/vdab178 |
PubMed ID | 34988456 |
PubMed Central ID | PMC8713741 |